Search By Initial

Cas Index 1

• 1803274-65-8 | BAY-1436032 (Catalog# : 181181)BAY-1436032 is a potent, selective and orally available inhibitor of mutant Isocitrat
• 1446090-77-2;1446090-79-4 | BGB-283 (Catalog# : 17101620)BGB-283, also known as Beigene-283 or Lifirafenib, is a Novel potent and selective RA
• 1357920-84-3 | Belizatinib (Catalog# : 17101619)Belizatinib, also known as TSR-011, is an orally available inhibitor of both the rece
• 1420071-30-2 | Bioymifi (Catalog# : 1710165)Bioymifi is an DR5 activator (Kd = 1.2 µM; IC50 = 2 µM). Bioymifi induces apoptosis
• 1707289-21-1 | BLU-554 (Catalog# : 1710162)BLU-554 is a fibroblast growth factor receptor 4 (FGFR4) inhibitor potentially for th
• 1632118-69-4 | BAR-501 (Catalog# : 179821)BAR-501 is a selective GPBAR1 agonist devoid of any FXR agonistic activity. BAR501 ef
• 1207293-36-4 | BI-847325 (Catalog# : 83101)BI-847325 is an orally bioavailable, and selective dual MEK/Aurora kinase inhibitor w
• 1906919-67-2 | BAY-598 (Catalog# : 17982)BAY-598 is a potent, peptide-competitive chemical probe for SMYD2. BAY-598 has a uniq
• 1906920-28-2 | BAY-598 R-isomer (Catalog# : 17981)BAY-598 R-isomer is the R-isomer of BAY589. BAY-598 R-isomer may be used as a referen
• 171655-91-7 | Brasofensine (Catalog# : 17916)Brasofensine is a monoamine reuptake blocker is a phenyltropane that had been under d
• 1290541-46-6 | B02 (Catalog# : 1783013)B02, also known as RAD51-IN-02, is a RAD51 inhibitor. B02 can enhance DOX sensitivity
• 1703793-34-3 | BLU-285 (Catalog# : 1781003)BLU-285 is a potent and selective inhibitor of PDGFR D842V and KIT Exon 17 mutants an
• 1876467-74-1 | BAY-1895344 (Catalog# : 1781002)BAY-1895344 is developed for the treatment of patients with advanced solid tumors and
• 1263871-36-8 | BMS-932481 (Catalog# : 2017877)BMS-932481 modulates A Peptides in the Plasma and Cerebrospinal Fluid of Healthy Volu
• 1334493-07-0 | BP-1-102 (Catalog# : 17030606)BP-1-102 is a potent, orally bioavailable and selective STAT3 inhibitor. BP-1-102 bin
• 1799753-84-6 | BAY-876 (Catalog# : 17030604)BAY-876 is a potent and Selective GLUT1 Inhibitor. BAY-876 showed good metabolic stab
• 1137359-47-7 | BRD-7552 (Catalog# : 17030312)BRD-7552 is a PDX1 transcription factor inducer. It up regulates PDX1 expression in b
• 1821496-27-8 | BDA-366 (Catalog# : 17030305)BDA-366 is a BCL2-BH4 antagonist. BDA-366 suppresses human myeloma growth. BDA-366 in
• 1225037-39-7 | Bimiralisib (Catalog# : 17030116)Bimiralisib, also known as PQR309, is an orally bioavailable pan inhibitor of phospho
• 1197953-54-0 | Brigatinib (AP-26113) (Catalog# : 16122905)Brigatinib, also known as AP-26113, is an orally active, potent and selective Dual AL
• 189232-42-6 | Bohemine (Catalog# : 16122903)Bohemine is a potent and selective, cell-permeable, cyclin-dependent kinase (CDK) inh
• 1000998-59-3 | BMS-687453 (Catalog# : 16122902)BMS-687453 is a potent and selective peroxisome proliferator activated receptor (PPAR
• 130370-60-4 | Batimastat (Catalog# : 16122804)Batimastat (also known as BB-94) is a synthetic matrix metalloproteinase inhibitor th
• 1909226-00-1 | BDA-366 (Catalog# : 16122769)BDA-366 is a small-molecule Bcl2-BH4 domain antagonist and binds BH4 with high affini
• 1883429-21-7 | BI-7273 (Catalog# : 16122742)BI-7273 is a potent, selective, and cell-permeable BRD9 BD Inhibitor.
• 1883429-22-8 | BI-9564 (Catalog# : 16122740)BI-9564 is a selective inhibitor of BRD9 and BRD7 bromodomains with the IC50 of 75 nM
• 1584713-87-0 | BMS-983970 (Catalog# : 6111507)BMS-983970 is an oral pan-Notch inhibitor for the treatment of cancer.
• 1257213-50-5 | BMS-986020 (Catalog# : 61122)BMS-986020 is a lysophosphatidic acid 1 receptor antagonist. BMS-986020 is in Phase 2
• 104344-23-2 | (±)-Bisoprolol hemifumarate (Catalog# : 6111106)Bisoprolol is a selective type 1 adrenergic receptor blocker.Bisoprolol, on beta 1-ad
• 1118567-05-7 | Bexagliflozin(EGT1442) (Catalog# : 1673102)EGT1442, a potent and selective SGLT2 inhibitor, attenuates blood glucose and HbA(1c)